Sign Up to like & get
recommendations!
0
Published in 2024 at "Translational Psychiatry"
DOI: 10.1038/s41398-025-03499-w
Abstract: Second-generation antipsychotics (SGAs) are widely used to treat schizophrenia (SCZ), but they often induce metabolic side effects like dyslipidemia and obesity. We conducted genome-wide association studies (GWASs) to identify genetic variants associated with SGA-induced lipid…
read more here.
Keywords:
induced lipid;
genome wide;
lipid bmi;
wide association ... See more keywords